Doug Hampton

LoneStar Tracking Launches an Innovative, Cost-Effective Automated Freezer Monitoring System

by

HOUSTON, June 1, 2023 /PRNewswire/ — LoneStar Tracking, a leader in intelligent tracking solutions, is pleased to announce the launch of their groundbreaking automated freezer monitoring and alerting system. This pioneering technology promises to revolutionize the food storage and refrigeration industry, delivering peace of mind for businesses and homeowners alike. Freezer temperature monitoring system This … Read more

L’Isle-Jourdain: a positive collective reflection on the theme of community health

by

the essential After the screening of the documentary “Another care is possible”, which presents the Village 2 health initiative, a rich debate took place in the room of the MJC. The Les chemins despossibles festival continues with regular events. This is how the MJC hosted the screening of the documentary “Another care is possible” which … Read more

BioCentriq® Launches LEAP™ Advanced Therapy Platform with Proven Assets and Expertise that Help Early-Stage BioTech Companies Reach Patients in Record Time

by

Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, N.J., June 1, 2023 /PRNewswire/ — BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy launched their new LEAP™ Advanced Therapy Platform today at the 29th International Society for Cell & Gene Therapy (ISCT) annual event. LEAP™ Platform … Read more

CANTEX PHARMACEUTICALS OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO INTELLECTUAL PROPERTY FROM GEORGETOWN UNIVERSITY FOR AZELIRAGON AS A POTENTIAL TREATMENT OF CANCER-RELATED COGNITIVE DECLINE

by

Cantex to Expand Collaboration with Georgetown’s Lombardi Comprehensive Cancer Center WESTON, Fla., June 1, 2023 /PRNewswire/ — Cantex Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed, today announced that it has obtained an exclusive worldwide license from Georgetown University … Read more

New Real-World Evidence from Personalized Trials Calls for Rethinking the Standard of Care for Non-Responders to Autoimmune Therapies

by

Personalized trials help patients achieve major reductions in joint flares and concomitant Rx in 17 weeks, while delivering $11k average autoimmune biologic and targeted therapy savings per non-responder annually. NEW YORK, June 1, 2023 /PRNewswire/ — Today Mymee Inc, a pioneer in personalized trials & care for patients with uncontrolled autoimmune and long COVID disease … Read more

CSOFT to Host June Soiree at Harvard Art Museums, Exhibit at 2023 DIA Global in Boston

by

BOSTON, June 1, 2023 /PRNewswire/ — CSOFT Health Sciences, leaders in clinical trial localization, are pleased to announce their return as exhibitors to DIA’s 2023 Annual Meeting, taking place June 25th – 29th at the Boston Conference and Exhibition Center in the Seaport neighborhood. With its attendance at booth #317, CSOFT reinforces its support for … Read more